Recently, the NUMEN Silk three-dimensional electrolytic detachment coil independently developed by MicroPort Medical Science Co., Ltd., a subsidiary of MicroPort Brain Science Co., Ltd., was approved for marketing by the State Drug Administration.
The NUMEN Silk three-dimensional electrolytic coil is an iterative product developed by Shentong Medical based on the NUMEN detachable embolic coil. Previously, NUMEN's detachable embolic coil was approved for marketing in China in September 2020, and has successively obtained EU CE certification, US FDA registration and Korean MFDS approval, and its clinical performance has been unanimously recognized by doctors at home and abroad. The newly launched NUMEN Silk three-dimensional electrolytic coil is suitable for embolization of small, medium, micro and ruptured aneurysms. Its three-dimensional Ω+S structure can conform to the irregular aneurysm wall, and has a variety of diameters and lengths. It is suitable for clinical treatment Offers a wider range of options.
As a new generation of ultra-soft electrolytic coils, NUMEN Silk’s ultra-thin primary wire diameter ensures the softness of the coils, which can minimize the pressure on the aneurysm wall and reduce the risk of aneurysm rupture during surgery; the most distal end of the push rod is ultra-soft The design further improves the flexibility of the push rod, making it as soft as a spring coil. With the ultra-short relief area, it can reduce the phenomenon of "kicking the tube" during the operation and achieve a silky filling effect, thereby obtaining a safer and more effective aneurysm embolization.
Intracranial aneurysms often occur at the bifurcations of cerebral arteries and the branches of the main trunk, where the muscular layer of the arterial wall is weakly developed and is greatly impacted by blood. Under the action of long-term blood flow pressure and impact force, the weak point gradually expands outward and is easy to form Aneurysm. According to statistics, the incidence rate of unruptured aneurysms is about 7% among people aged 35 to 75 in my country. The chance of an aneurysm rupturing increases over time, and once ruptured, the rate of death and disability is high. Cerebral aneurysm embolization uses a minimally invasive approach to pack coils into the tumor to form a thrombus to stagnate blood flow and reduce intratumoral pressure, thereby reducing the possibility of tumor rupture.
The approval of NUMEN Silk for marketing in China means that Shentong Medical's product iteration speed and upgrade ability have been further recognized, and it has provided more safe and effective clinical options in the field of hemorrhagic stroke treatment. Shentong Medical said that in the future, the company will continue to focus on clinical needs, continue to promote product innovation, research and development and iterative upgrades, provide doctors with safer, more convenient and effective clinical solutions, and provide patients with better quality and affordable stroke disease treatment plan
